Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)

Kubota Pharmaceutical Holdings

15/05/2018 07:00

May 15 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended        Year to  
                  Mar 31, 2018        Mar 31, 2017      Dec 31, 2018  
                     LATEST             YEAR-AGO           COMPANY    
                     RESULTS             RESULT           FORECAST    
  Sales               0 mln               0 mln                       
  Operating       loss 751 mln          loss 1.08         loss 3.50   
  Pretax          loss 696 mln          loss 1.04         loss 3.37   
  Net             loss 696 mln          loss 1.04         loss 3.37   
  EPS Basic      loss 18.32 yen      loss 27.44 yen    loss 88.60 yen 
  EPS Diluted    loss 18.32 yen      loss 27.44 yen                   
  Ann Div                                  NIL               NIL      
  -Q2 Div                                  NIL               NIL      
  -Q4 Div                                  NIL               NIL      
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T